These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 35737038)
1. Correlation Investigation between Pyrrole-DNA and Pyrrole-Protein Adducts in Male ICR Mice Exposed to Retrorsine, a Hepatotoxic Pyrrolizidine Alkaloid. Zhu L; Xue J; He Y; Xia Q; Fu PP; Lin G Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737038 [TBL] [Abstract][Full Text] [Related]
2. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts. Ma J; Li M; Li N; Chan WY; Lin G Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016 [TBL] [Abstract][Full Text] [Related]
3. The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity. Lu Y; Ma J; Song Z; Ye Y; Fu PP; Lin G Arch Toxicol; 2018 Nov; 92(11):3403-3414. PubMed ID: 30244272 [TBL] [Abstract][Full Text] [Related]
4. Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity. Ma J; Xia Q; Fu PP; Lin G J Food Drug Anal; 2018 Jul; 26(3):965-972. PubMed ID: 29976414 [TBL] [Abstract][Full Text] [Related]
5. 7-Glutathione-pyrrole and 7-cysteine-pyrrole are potential carcinogenic metabolites of pyrrolizidine alkaloids. He X; Xia Q; Fu PP J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2017 Apr; 35(2):69-83. PubMed ID: 28418776 [TBL] [Abstract][Full Text] [Related]
6. Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human. Zhu L; Zhang C; Zhang W; Xia Q; Ma J; He X; He Y; Fu PP; Jia W; Zhuge Y; Lin G Arch Toxicol; 2021 Oct; 95(10):3191-3204. PubMed ID: 34390356 [TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo. Wang YP; Fu PP; Chou MW Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803 [TBL] [Abstract][Full Text] [Related]
8. The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice. Zhu L; Xue J; Xia Q; Fu PP; Lin G Arch Toxicol; 2017 Feb; 91(2):949-965. PubMed ID: 27125825 [TBL] [Abstract][Full Text] [Related]
9. Pyrrolizidine alkaloid-derived DNA adducts are common toxicological biomarkers of pyrrolizidine alkaloid N-oxides. He X; Xia Q; Woodling K; Lin G; Fu PP J Food Drug Anal; 2017 Oct; 25(4):984-991. PubMed ID: 28987376 [TBL] [Abstract][Full Text] [Related]
10. Primary and secondary pyrrolic metabolites of pyrrolizidine alkaloids form DNA adducts in human A549 cells. He X; Xia Q; Wu Q; Tolleson WH; Lin G; Fu PP Toxicol In Vitro; 2019 Feb; 54():286-294. PubMed ID: 30366057 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids. Song Z; He Y; Ma J; Fu PP; Lin G J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835 [TBL] [Abstract][Full Text] [Related]
12. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation. Xia Q; He X; Ma L; Chen S; Fu PP Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181 [TBL] [Abstract][Full Text] [Related]
13. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity. Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity. Yang M; Ruan J; Fu PP; Lin G Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561 [TBL] [Abstract][Full Text] [Related]
15. Antibody-based detection of lysine modification of hepatic protein in mice treated with retrorsine. Cheng T; Li W; Yang X; Wang H; Zhang F; Li N; Lin G; Zheng J J Environ Sci Health C Toxicol Carcinog; 2020; 38(4):315-328. PubMed ID: 33382013 [TBL] [Abstract][Full Text] [Related]
16. 1-Formyl-7-hydroxy-6,7-dihydro-5 H-pyrrolizine (1-CHO-DHP): A Potential Proximate Carcinogenic Metabolite of Pyrrolizidine Alkaloids. He X; Xia Q; Gamboa da Costa G; Lin G; Fu PP Chem Res Toxicol; 2019 Jun; 32(6):1193-1203. PubMed ID: 31120748 [TBL] [Abstract][Full Text] [Related]
17. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673 [TBL] [Abstract][Full Text] [Related]
18. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica. Chen Y; Xiong F; Wang W; Jiang K; Ye X; Deng G; Wang C; Yang L; Xiong A; Wang Z Toxicol Lett; 2020 May; 323():41-47. PubMed ID: 31982501 [TBL] [Abstract][Full Text] [Related]
19. Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans. Ma J; Zhang W; He Y; Zhu L; Zhang C; Liu J; Ye Y; Zhuge Y; Lin G Arch Toxicol; 2021 Feb; 95(2):759-765. PubMed ID: 33210216 [TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis. Ruan J; Yang M; Fu P; Ye Y; Lin G Chem Res Toxicol; 2014 Jun; 27(6):1030-9. PubMed ID: 24836403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]